Literature DB >> 2380108

A54145, a new lipopeptide antibiotic complex: microbial and chemical modification.

D S Fukuda1, M Debono, R M Molloy, J S Mynderse.   

Abstract

A54145 is a complex of acidic lipopeptide antibiotics produced by Streptomyces fradiae NRRL 18158, NRRL 18159, and NRRL 18160. Each antibiotic factor consists of a peptide core bearing an N-terminal acyl substituent. N-Lys-tert-BOC-protected A54145 complex was deacylated by Actinoplanes utahensis; three protected core peptides were isolated. A54145 antibiotic analogs were synthesized by acylation of the tryptophan N-terminus with 2,4,5-trichlorophenyl active esters, followed by deblocking with trifluoroacetic acid.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2380108     DOI: 10.7164/antibiotics.43.601

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  4 in total

1.  The lipopeptide antibiotic A54145 biosynthetic gene cluster from Streptomyces fradiae.

Authors:  Vivian Miao; Renee Brost; Joanne Chapple; Kevin She; Marie-François Coëffet-Le Gal; Richard H Baltz
Journal:  J Ind Microbiol Biotechnol       Date:  2005-10-06       Impact factor: 3.346

2.  Development of a genetic system for combinatorial biosynthesis of lipopeptides in Streptomyces fradiae and heterologous expression of the A54145 biosynthesis gene cluster.

Authors:  Dylan C Alexander; Jessica Rock; Xiaowei He; Paul Brian; Vivian Miao; Richard H Baltz
Journal:  Appl Environ Microbiol       Date:  2010-08-27       Impact factor: 4.792

3.  Membrane Binding and Oligomerization of the Lipopeptide A54145 Studied by Pyrene Fluorescence.

Authors:  TianHua Zhang; Scott D Taylor; Michael Palmer; Jean Duhamel
Journal:  Biophys J       Date:  2016-09-20       Impact factor: 4.033

4.  Deacylation of Calcium-Dependent Antibiotics from Streptomyces violaceoruber in Co-culture with Streptomyces sp. MG7-G1.

Authors:  Kathrin Schindl; Deepika Sharma; Dieter Spiteller
Journal:  Chembiochem       Date:  2020-07-20       Impact factor: 3.164

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.